Evolus, Inc.
(NASDAQ : EOLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.50%43.970.9%$1186.44m
ABBVAbbVie, Inc. -0.22%107.121.9%$1023.77m
JNJJohnson & Johnson -0.23%164.480.7%$988.09m
MRKMerck & Co., Inc. 0.81%73.640.7%$914.30m
LLYEli Lilly & Co. -0.26%231.581.1%$588.95m
BMYBristol-Myers Squibb Co. -0.61%60.261.0%$575.61m
AZNAstraZeneca Plc 1.46%60.351.0%$353.10m
NVSNovartis AG -0.75%82.950.2%$156.40m
CRVSCorvus Pharmaceuticals, Inc. -3.27%6.800.7%$140.27m
GSKGlaxoSmithKline Plc -2.44%38.380.2%$135.32m
RGENRepligen Corp. -0.29%323.266.8%$123.14m
SNYSanofi -1.60%47.940.2%$122.20m
RPRXRoyalty Pharma Plc -0.08%37.100.1%$121.13m
VTRSViatris, Inc. 0.30%13.380.0%$107.54m
NVONovo Nordisk A/S -1.36%100.710.1%$101.76m

Company Profile

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.